About the Company
We do not have any company description for HeartBeam, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
18
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 13, 2025 HeartBeam, Inc. beats earnings expectations. Reported EPS is $-0.15, ...
Earnings To Watch: HeartBeam Inc (BEAT) Reports Q2 2025 Result
HeartBeam Inc (NASDAQ:BEAT) is set to release its Q2 2025 earnings on Aug 13, 2025. The consensus estimate for Q2 2025 ...
HeartBeam Inc (BEAT) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Discipline
HeartBeam Inc (BEAT) showcases FDA clearances and innovation while managing cash burn and preparing for commercialization.
HeartBeam Advances Toward ECG Software Commercialization
Heartbeam, Inc. ( ($BEAT) ) has released its Q2 earnings. Here is a breakdown of the information Heartbeam, Inc. presented to its investors.
Multiple insiders bought HeartBeam, Inc. (NASDAQ:BEAT) stock earlier ...
Insiders at HeartBeam Have Bought Stock Recently Over the last three months, we've seen a bit of insider buying at HeartBeam. Chief Financial Officer Richard Brounstein shelled out US$17k for ...
HeartBeam Broadens Product Portfolio Pipeline with Smartwatch ...
HeartBeam, Inc., a cardiac technology company that has developed the first and only 3 D-vector ECG platform for heart attack detection anytime, anywhere, announced today the expansion of its ...
HeartBeam Announces Automated Cardiac Detection Patent Granted for ...
About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform intended for patient use at home.
HeartBeam, Inc. (BEAT) Q1 2023 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ETCompany ParticipantsBranislav Vajdic - Founder and Chief Executive ...
HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch ...
About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere.
What's Going On With Heartbeam (BEAT) Stock?
Heartbeam shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The company last week said it secured two new patents.
HeartBeam Inc. (NASDAQ: BEAT) On Track to Advance Innovative Products
HeartBeam has two patented products in development. HeartBeam AIMI (TM) is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately ...
HeartBeam, Inc. (BEAT) Q2 2023 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ: BEAT) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Branislav Vajdic - Founder & Chief Executive Officer Robert Eno - President Richard ...
Similar Companies
Loading the latest forecasts...